S&P 500   3,934.11 (-0.18%)
DOW   33,617.94 (+0.06%)
QQQ   280.41 (-0.45%)
AAPL   141.27 (-1.15%)
MSFT   244.39 (-0.30%)
META   113.43 (-0.60%)
GOOGL   95.35 (-1.68%)
AMZN   88.03 (-0.25%)
TSLA   173.28 (-3.64%)
NVDA   159.53 (-0.21%)
NIO   12.56 (-5.14%)
BABA   88.68 (-3.03%)
AMD   70.48 (+0.30%)
T   19.37 (+1.04%)
MU   53.53 (-0.28%)
CGC   3.33 (-7.76%)
F   13.29 (+0.08%)
GE   85.34 (+0.07%)
DIS   92.24 (-0.05%)
AMC   6.47 (-4.15%)
PYPL   74.09 (+2.58%)
PFE   50.43 (+1.45%)
NFLX   306.32 (+0.25%)
S&P 500   3,934.11 (-0.18%)
DOW   33,617.94 (+0.06%)
QQQ   280.41 (-0.45%)
AAPL   141.27 (-1.15%)
MSFT   244.39 (-0.30%)
META   113.43 (-0.60%)
GOOGL   95.35 (-1.68%)
AMZN   88.03 (-0.25%)
TSLA   173.28 (-3.64%)
NVDA   159.53 (-0.21%)
NIO   12.56 (-5.14%)
BABA   88.68 (-3.03%)
AMD   70.48 (+0.30%)
T   19.37 (+1.04%)
MU   53.53 (-0.28%)
CGC   3.33 (-7.76%)
F   13.29 (+0.08%)
GE   85.34 (+0.07%)
DIS   92.24 (-0.05%)
AMC   6.47 (-4.15%)
PYPL   74.09 (+2.58%)
PFE   50.43 (+1.45%)
NFLX   306.32 (+0.25%)
S&P 500   3,934.11 (-0.18%)
DOW   33,617.94 (+0.06%)
QQQ   280.41 (-0.45%)
AAPL   141.27 (-1.15%)
MSFT   244.39 (-0.30%)
META   113.43 (-0.60%)
GOOGL   95.35 (-1.68%)
AMZN   88.03 (-0.25%)
TSLA   173.28 (-3.64%)
NVDA   159.53 (-0.21%)
NIO   12.56 (-5.14%)
BABA   88.68 (-3.03%)
AMD   70.48 (+0.30%)
T   19.37 (+1.04%)
MU   53.53 (-0.28%)
CGC   3.33 (-7.76%)
F   13.29 (+0.08%)
GE   85.34 (+0.07%)
DIS   92.24 (-0.05%)
AMC   6.47 (-4.15%)
PYPL   74.09 (+2.58%)
PFE   50.43 (+1.45%)
NFLX   306.32 (+0.25%)
S&P 500   3,934.11 (-0.18%)
DOW   33,617.94 (+0.06%)
QQQ   280.41 (-0.45%)
AAPL   141.27 (-1.15%)
MSFT   244.39 (-0.30%)
META   113.43 (-0.60%)
GOOGL   95.35 (-1.68%)
AMZN   88.03 (-0.25%)
TSLA   173.28 (-3.64%)
NVDA   159.53 (-0.21%)
NIO   12.56 (-5.14%)
BABA   88.68 (-3.03%)
AMD   70.48 (+0.30%)
T   19.37 (+1.04%)
MU   53.53 (-0.28%)
CGC   3.33 (-7.76%)
F   13.29 (+0.08%)
GE   85.34 (+0.07%)
DIS   92.24 (-0.05%)
AMC   6.47 (-4.15%)
PYPL   74.09 (+2.58%)
PFE   50.43 (+1.45%)
NFLX   306.32 (+0.25%)
OTCMKTS:HYPMY

Hypera - HYPMY Stock Forecast, Price & News

$7.98
-0.19 (-2.33%)
(As of 12/6/2022 12:00 AM ET)
Add
Compare
Today's Range
$7.90
$8.02
50-Day Range
$7.76
$9.60
52-Week Range
$4.63
$9.60
Volume
3,501 shs
Average Volume
15,368 shs
Market Capitalization
$5.05 billion
P/E Ratio
N/A
Dividend Yield
1.90%
Price Target
N/A
HYPMY stock logo

About Hypera (OTCMKTS:HYPMY) Stock

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex - A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company also provides dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo Química, Sodium Diclofenac, Hydroxyzine, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brand names. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. is based in São Paulo, Brazil.

Receive HYPMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hypera and its competitors with MarketBeat's FREE daily newsletter.

HYPMY Stock News Headlines

Hypera SA ADR - Stock Quote HYPMY
Hypera S/A ADR
Brazil's Hypera to sell Xantinon drug to Uniao Quimica
Brazilian drugmaker Hypera cuts 2020 revenue outlook
A Potentially Overlooked Trio to Consider
See More Headlines
Receive HYPMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hypera and its competitors with MarketBeat's FREE daily newsletter.

HYPMY Company Calendar

Today
12/07/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:HYPMY
Fax
N/A
Employees
8,918
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$793.81 million
Cash Flow
$0.43 per share
Book Value
$2.83 per share

Miscellaneous

Free Float
N/A
Market Cap
$5.05 billion
Optionable
Not Optionable
Beta
0.75

Key Executives

  • Mr. Breno Toledo Pires de Oliveira
    CEO & Director
  • Mr. Adalmario Ghovatto Satheler do Couto
    Investor Relations Officer & CFO
  • Mr. Carlos Roberto Scorsi (Age 60)
    Chief Operating officer
  • Juliana Aguinaga Damião Salem
    Sr. Legal Officer
  • Joao Felipe Khamis Aguilar
    Risks & Compliance Officer
  • Mr. Luiz Eduardo Sales Clavis
    VP of Sales & Marketing
  • Mauricio Christovam
    Sr. HR Officer
  • Mr. Nelson José de Mello (Age 63)
    Chief Corp. Relations Officer
  • Mr. Hélio Segouras
    Head of Consumer Health
  • Mr. Martim Prado Mattos (Age 42)
    Sec.













HYPMY Stock - Frequently Asked Questions

Should I buy or sell Hypera stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Hypera in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" HYPMY shares.
View HYPMY analyst ratings
or view top-rated stocks.

How have HYPMY shares performed in 2022?

Hypera's stock was trading at $5.00 at the beginning of the year. Since then, HYPMY shares have increased by 59.6% and is now trading at $7.98.
View the best growth stocks for 2022 here
.

Is Hypera a good dividend stock?

Hypera (OTCMKTS:HYPMY) pays an annual dividend of $0.16 per share and currently has a dividend yield of 1.90%.
Read our dividend analysis for HYPMY.

What is Hypera's stock symbol?

Hypera trades on the OTCMKTS under the ticker symbol "HYPMY."

How do I buy shares of Hypera?

Shares of HYPMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Hypera's stock price today?

One share of HYPMY stock can currently be purchased for approximately $7.98.

How much money does Hypera make?

Hypera (OTCMKTS:HYPMY) has a market capitalization of $5.05 billion and generates $793.81 million in revenue each year.

How many employees does Hypera have?

The company employs 8,918 workers across the globe.

How can I contact Hypera?

Hypera's mailing address is AV. MAGALHAES DE CASTRO 4800 - 24¿ ANDAR EDIFICIO CONTINENTAL TOWER, SAO PAULO D5, 05676-120. The official website for the company is www.hyperapharma.com.br. The company can be reached via phone at 55-11-3627-4206 or via email at ir@hypera.com.

This page (OTCMKTS:HYPMY) was last updated on 12/7/2022 by MarketBeat.com Staff